|
1
|
Sala Torra O and Loeb KR: Donor
cell-derived leukemia and myelodysplastic neoplasm: Unique forms of
leukemia. Am J Clin Pathol. 135:501–504. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang E, Hutchison CB, Huang Q, Lu CM, Crow
J, Wang FF, Sebastian S, Rehder C, Lagoo A, Horwitz M, et al: Donor
cell-derived leukemias/myelodysplastic neoplasms in allogeneic
hematopoietic stem cell transplant recipients: A clinicopathologic
study of 10 cases and a comprehensive review of the literature. Am
J Clin Pathol. 135:525–540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wiseman DH: Donor cell leukemia: A review.
Biol Blood Marrow Transplant. 17:771–789. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Browne PV, Lawler M, Humphries P and
McCann SR: Donor-cell leukemia after bone marrow transplantation
for severe aplastic anemia. N Engl J Med. 325:710–713. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lawler M, Locasciulli A, Longoni D, Schiro
R and McCann SR: Leukaemic transformation of donor cells in a
patient receiving a second allogeneic bone marrow transplant for
severe aplastic anaemia. Bone Marrow Transplant. 29:453–456. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Catovsky D, Matutes E, Buccheri V, Shetty
V, Hanslip J, Yoshida N and Morilla R: A classification of acute
leukaemia for the 1990s. Ann Hematol. 62:16–21. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fialkow PJ, Thomas ED, Bryant JI and
Neiman PE: Leukaemic transformation of engrafted human marrow cells
in vivo. Lancet. 1:251–255. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hertenstein B, Hambach L, Bacigalupo A,
Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A,
Schwertfeger R, et al: Chronic Leukaemia Working Party of the
European Group for Blood and Marrow Transplantation: Development of
leukemia in donor cells after allogeneic stem cell transplantation
- a survey of the European Group for Blood and Marrow
Transplantation (EBMT). Haematologica. 90:969–975. 2005.PubMed/NCBI
|
|
9
|
Hashino S, Fujisawa F, Kondo T, Imamura M,
Sato K, Torimoto Y, Kohgo Y, Kimura K, Furukawa H, Todo S and Asaka
M: Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7
after allogeneic peripheral blood stem cell transplantation and
liver transplantation in a patient with severe-type aplastic
anemia. Int J Hematol. 84:363–366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haltrich I, Müller J, Szabó J, Kovács G,
Kóos R, Poros A, Dobos M and Fekete G: Donor-cell myelodysplastic
syndrome developing 13 years after marrow grafting for aplastic
anemia. Cancer Genet Cytogenet. 142:124–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruiz-Argüelles GJ, Ruiz-Argüelles A and
Garcés-Eisele J: Donor cell leukemia: A critical review. Leuk
Lymphoma. 48:25–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Flynn CM and Kaufman DS: Donor cell
leukemia: Insight into cancer stem cells and the stem cell niche.
Blood. 109:2688–2692. 2007.PubMed/NCBI
|
|
13
|
Socié G, Henry-Amar M, Bacigalupo A, Hows
J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't
Veer-Korthof E and Gluckman E: European Bone Marrow
Transplantation-Severe Aplastic Anaemia Working Party: Malignant
tumors occurring after treatment of aplastic anemia. N Engl J Med.
329:1152–1157. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kojima S, Ohara A, Tsuchida M, Kudoh T,
Hanada R, Okimoto Y, Kaneko T, Takano T, Ikuta K and Tsukimoto I:
Japan Childhood Aplastic Anemia Study Group: Risk factors for
evolution of acquired aplastic anemia into myelodysplastic syndrome
and acute myeloid leukemia after immunosuppressive therapy in
children. Blood. 100:786–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saracco P, Quarello P, Iori AP, Zecca M,
Longoni D, Svahn J, Varotto S, Del Vecchio GC, Dufour C, Ramenghi
U, et al: Bone Marrow Failure Study Group of the AIEOP (Italian
Association of Paediatric Haematology Oncology): Cyclosporin A
response and dependence in children with acquired aplastic anaemia:
A multicentre retrospective study with long-term observation
follow-up. Br J Haematol. 140:197–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaito K, Kobayashi M, Katayama T, Masuoka
H, Shimada T, Nishiwaki K, Sekita T, Otsubo H, Ogasawara Y and
Hosoya T: Long-term administration of G-CSF for aplastic anaemia is
closely related to the early evolution of monosomy 7 MDS in adults.
Br J Haematol. 103:297–303. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Witherspoon RP, Fisher LD, Schoch G,
Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb
R and Thomas ED: Secondary cancers after bone marrow
transplantation for leukemia or aplastic anemia. N Engl J Med.
321:784–789. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moore KA and Lemischka IR: Stem cells and
their niches. Science. 311:1880–1885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Z and Li L: Understanding hematopoietic
stem-cell microenvironments. Trends Biochem Sci. 31:589–595. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang SR, Salup RR, Urias PE, Twilley TA,
Talmadge JE, Herberman RB and Wiltrout RH: Augmentation of NK
activity and/or macrophage-mediated cytotoxicity in the liver by
biological response modifiers including human recombinant
interleukin 2. Cancer Immunol Immunother. 21:19–25. 1986.
View Article : Google Scholar : PubMed/NCBI
|
